San Diego CA— Lysulin, Inc., a first-in-class nutritional supplement formulated for people with Type 2 diabetes and prediabetes, announced today further expansion of its flagship product, Lysulin®, with Walmart, Inc. (NYSE: WMT). The Company’s expanded retail distribution includes their bestselling Lysulin Chewable Tablets (Berry Flavored, 180ct). Lysulin’s easy-to-take, chewable tablet is gluten free, vegetarian and vegan.
Lysulin provides a breakthrough approach for blood glucose management in an all-natural product available over the counter, without a prescription. Formulated by renowned diabetes scientist, Dr. John Burd, Lysulin contains a proprietary blend of Lysine, Zinc and Vitamin C. Lysulin is patented and proven in a human clinical study to help people with diabetes and prediabetes maintain healthy levels of A1c blood sugar and improve insulin resistance.
“We are excited to partner with Walmart to help get Lysulin to even more people across the country,” said Dr. John Burd, Founder and Chief Executive Officer of Lysulin, Inc. “National retailers are keenly aware of the increased consumer demand for natural, over the counter supplements and the importance of partnering with brands that are backed by clinical studies and proven research. We look forward to our continued growth as we expand distribution with our retail partners.”